Non-compliance with treatment in patients suffering from schizophrenia: A study to evaluate possible contributing factors

被引:54
作者
Agarwal, MR
Sharma, VK
Kumar, KKV
Lowe, D
机构
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Fazakerley Dist Gen Hosp, Dept Psychiat, Liverpool, Merseyside, England
[3] Fazakerley Dist Gen Hosp, Clin Audit Unit, Liverpool, Merseyside, England
关键词
D O I
10.1177/002076409804400202
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background. Various factors have been associated with non-compliance with treatment in schizophrenia. The aim of this study was to examine this association using standardised measures. Method. Compliance was determined and socio-demographic and illness variables recorded. Insight, subjective response to medication and relatives' knowledge and attitude about schizophrenia were measured. Results. Non-compliant patients were younger, had shorter durations of illness, had an episodic course of illness, reported side-effects less frequently, made incorrect attributions to current positive symptoms more frequently and had a more negative subjective response to medication. Key relatives of non-compliant patients were more often employed. Conclusions. Patients need to experience for themselves the merits of taking medication before accepting the need to take them long-term. Psychoeducational and cognitive-behavioural interventions need to be targeted at changing attributions to current positive symptoms. The presence of a key person in the community is crucial to improve compliance.
引用
收藏
页码:92 / 106
页数:15
相关论文
共 27 条
[1]  
AMADOR XF, 1993, AM J PSYCHIAT, V150, P873
[2]   LAY BELIEFS ABOUT SCHIZOPHRENIC DISORDER - THE RESULTS OF A POPULATION SURVEY IN GERMANY [J].
ANGERMEYER, MC ;
MATSCHINGER, H .
ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 :39-45
[3]  
[Anonymous], 1994, Cognitive-behavioral therapy of schizophrenia
[4]  
Barrowclough C., 1992, FAMILIES SCHIZOPHREN
[5]   MULTIPLE SIGNIFICANCE TESTS - THE BONFERRONI METHOD .10. [J].
BLAND, JM ;
ALTMAN, DG .
BRITISH MEDICAL JOURNAL, 1995, 310 (6973) :170-170
[6]  
BRISTOW MF, 1993, CLINICIAN, V11, P55
[7]   A 2-YEAR PROSPECTIVE-STUDY OF TREATMENT COMPLIANCE IN PATIENTS WITH SCHIZOPHRENIA [J].
BUCHANAN, A .
PSYCHOLOGICAL MEDICINE, 1992, 22 (03) :787-797
[8]   THE PREDICTABILITY OF RELAPSES IN SCHIZOPHRENIC-PATIENTS [J].
BUCHKREMER, G ;
STRICKER, K ;
HOLLE, R ;
KUHS, H .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1991, 240 (4-5) :292-300
[9]  
DAVIS JM, 1986, J CLIN PSYCHOPHARM, V6, P2
[10]   FAMILY MANAGEMENT IN THE PREVENTION OF EXACERBATIONS OF SCHIZOPHRENIA - A CONTROLLED-STUDY [J].
FALLOON, IRH ;
BOYD, JL ;
MCGILL, CW ;
RAZANI, J ;
MOSS, HB ;
GILDERMAN, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (24) :1437-1440